Guggenheim cuts Septerna stock price target to $45 on CSU study risk

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Guggenheim raises Assembly Biosciences stock price target on herpes drug progress Hisse Senetleri 0 22
A Guggenheim reiterates Forte Biosciences stock rating ahead of data Hisse Senetleri 0 16
A Guggenheim reiterates Buy on Biogen stock after Apellis deal Hisse Senetleri 0 26
A Guggenheim lowers Eli Lilly stock price target to $1,163 on Q1 estimates Hisse Senetleri 0 22
A Guggenheim reiterates Buy on Pyxis Oncology stock ahead of trial data Hisse Senetleri 0 41
A Apogee Therapeutics stock price target raised to $160 by Guggenheim on trial data Hisse Senetleri 0 43
A Guggenheim raises Pfizer stock price target on drug trial outlook Hisse Senetleri 0 45
A Guggenheim initiates Generate Biomedicines stock with buy rating Hisse Senetleri 0 25

Benzer konular

Üst